Indicated for: multiple sclerosis
Route of administration: injectable
Substance: interferon beta 1B (interferon)
ATC: L03AB08 (Antineoplastic and immunomodulating agents | Immunostimulants | Interferons)
Interferon beta-1B is a medication used for the treatment of relapsing and secondary progressive multiple sclerosis. It works by reducing inflammation and modulating the immune response, helping to reduce the frequency of relapses and slow disease progression.
The medication is administered as a subcutaneous injection, as directed by a doctor, usually once every other day. It is important for patients to follow the treatment regimen and undergo regular check-ups.
Patients should be aware of potential side effects, such as flu-like symptoms, injection site reactions, or fatigue. It is important to inform the doctor of any unusual symptoms.
Common side effects include flu-like symptoms, injection site reactions, and fatigue. In rare cases, severe reactions such as depression or liver impairment may occur. Patients should be informed of these risks before starting treatment.